Erratum: P-cadherin functional role is dependent on E-cadherin cellular context: A proof of concept using the breast cancer model (Journal of Pathology 2013) 229 (708-718) DOI: 10.1002/path.4143);P-cadherin functional role is dependent on E-cadherin cellular context: A proof of concept using the breast cancer model

Journal of Pathology

Volumn 229, Issue 5, 2013, Pages 705-718

  Ribeiro, Ana Sofia ^a   Sousa, Bárbara ^a   Carreto, Laura ^b   Mendes, Nuno ^a   Nobre, Ana Rita ^a   Ricardo, Sara ^a   Albergaria, André ^a   Cameselle Teijeiro, Jorge F ^c   Gerhard, Rene ^a   Söderberg, Ola ^d   Seruca, Raquel ^a,e   Santos, Manuel A ^b   Schmitt, Fernando ^a   Paredes, Joana ^a,e  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^d UPPSALA UNIVERSITY   (Sweden)

^e University of Porto   (Portugal)

Author keywords

breast cancer; E cadherin; invasion; motility; P cadherin

Indexed keywords

CATENIN; CELL PROTEIN; COMPLEMENTARY DNA; P CADHERIN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DNA MICROARRAY; FEMALE; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; WILD TYPE;

EID: 84875054847     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4722     Document Type: Erratum

References (72)

1. Gumbiner BM,. Regulation of cadherin-mediated adhesion in morphogenesis. Nature Rev Mol Cell Biol 2005; 6: 622-634.
2. Takeichi M., Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
3. Cavallaro U, Schaffhauser B, Christofori G,. Cadherins and the tumour progression: is it all in a switch? Cancer Lett 2002; 176: 123-128.
4. Oliveira C, Seruca R, Carneiro F,. Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009; 23: 147-157.
5. De Leeuw WJ, Berx G, Vos CB, et al., Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404-411.
6. Berx G, Cleton-Jansen AM, Nollet F, et al., E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107-6115.
7. Vos CB, Cleton-Jansen AM, Berx G, et al,. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131-1133.
8. Baranwal S, Alahari SK,. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 2009; 384: 6-11.
9. Oliveira C, Sousa S, Pinheiro H, et al,. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009; 136: 2137-2148.
10. Suriano G, Oliveira C, Ferreira P, et al,. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003; 12: 575-582.
11. Reynolds AB, Carnahan RH,. Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer. Semin Cell Dev Biol 2004; 15: 657-663.
12. Schackmann RC, van Amersfoort M, Haarhuis JH, et al,. Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. J Clin Invest 2011; 121: 3176-3188.
13. Paredes J, Correia AL, Ribeiro AS, et al,. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival. J Clin Pathol 2008; 61: 856-862.
14. Imai K, Hirata S, Irie A, et al,. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Clin Cancer Res 2008; 14: 6487-6495.
15. Paredes J, Albergaria A, Oliveira JT, et al,. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 2005; 11: 5869-5877.
16. Paredes J, Correia AL, Ribeiro AS, et al,. P-cadherin expression in breast cancer: a review. Breast Cancer Res 2007; 9: 214.
17. Sousa B, Paredes J, Milanezi F, et al,. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histol Histopathol 2010; 25: 963-974.
18. Albergaria A, Ribeiro AS, Vieira AF, et al., P-cadherin role in normal breast development and cancer. Int J Dev Biol 2011; 55: 811-822.
19. Ribeiro AS, Albergaria A, Sousa B, et al,. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 2010; 29: 392-402.
20. Ben Hamida A, Labidi IS, Mrad K, et al,. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin. BMC Cancer 2008; 8: 28.
21. Paredes J, Stove C, Stove V, et al,. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res 2004; 64: 8309-8317.
22. Taniuchi K, Nakagawa H, Hosokawa M, et al,. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 2005; 65: 3092-3099.
23. Cheung LW, Mak AS, Cheung AN, et al,. P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin. Oncogene 2011; 30: 2964-2974.
24. Bauer K, Dowejko A, Bosserhoff AK, et al,. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. Carcinogenesis 2009; 30: 1781-1788.
25. Sarriõ D, Palacios J, Hergueta-Redondo M, et al,. Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer 2009; 9: 74.
26. Van Marck V, Stove C, Van Den Bossche K, et al,. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 2005; 65: 8774-8783.
27. Paredes J, Correia AL, Ribeiro AS, et al,. Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines. Cell Oncol 2007; 29: 467-476.
28. Huang da W, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protoc 2009; 4: 44-57.
29. Paredes J, Milanezi F, Viegas L, et al,. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch 2002; 440: 16-21.
30. Soderberg O, Gullberg M, Jarvius M, et al,. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nature Methods 2006; 3: 995-1000.
31. Bakin AV, Tomlinson AK, Bhowmick NA, et al,. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275: 36803-36810.
32. Thiery JP, Sleeman JP,. Complex networks orchestrate epithelial- mesenchymal transitions. Nature Rev Mol Cell Biol 2006; 7: 131-142.
33. Zavadil J, Bottinger EP,. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
34. Lin M, van Golen KL,. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat 2004; 84: 49-60.
35. Anastasiadis PZ,. p120-ctn: a nexus for contextual signaling via Rho GTPases. Biochim Biophys Acta 2007; 1773: 34-46.
36. Prakasam AK, Maruthamuthu V, Leckband DE,. Similarities between heterophilic and homophilic cadherin adhesion. Proc Natl Acad Sci U S A 2006; 103: 15434-15439.
37. Shi Q, Chien YH, Leckband D,. Biophysical properties of cadherin bonds do not predict cell sorting. J Biol Chem 2008; 283: 28454-28463.
38. Barber M, Murrell A, Ito Y, et al,. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 2008; 216: 295-306.
39. Masciari S, Larsson N, Senz J, et al,. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 2007; 44: 726-731.
40. Oliveira C, de Bruin J, Nabais S, et al,. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 2004; 23: 2236-2240.
41. Sundfeldt K., Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. Mol Cell Endocrinol 2003; 202: 89-96.
42. Reddy P, Liu L, Ren C, et al,. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells. Mol Endocrinol 2005; 19: 2564-2578.
43. Davidson B, Berner A, Nesland JM, et al,. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol 2000; 192: 460-469.
44. Saha B, Arase A, Imam SS, et al,. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Prostate 2008; 68: 78-84.
45. Lewis-Tuffin LJ, Rodriguez F, Giannini C, et al,. Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 2010; 5: e13665.
46. Querzoli P, Coradini D, Pedriali M, et al,. An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer 2010; 103: 1835-1839.
47. Tomlinson JS, Alpaugh ML, Barsky SH,. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 2001; 61: 5231-5241.
48. Dykxhoorn DM, Wu Y, Xie H, et al,. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 2009; 4: e7181.
49. Lou Y, Preobrazhenska O, auf dem Keller U, et al. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev Dyn 2008; 237: 2755-2768.
50. Longatto Filho A, Albergaria A, Paredes J, et al,. P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology. Cytopathology 2005; 16: 88-93.
51. Mialhe A, Levacher G, Champelovier P, et al,. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. J Urol 2000; 164: 826-835.
52. Turashvili G, McKinney SE, Goktepe O, et al,. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer. Mod Pathol 2011; 24: 64-81.
53. Cheung LW, Leung PC, Wong AS,. Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer. Oncogene 2010; 29: 2427-2440.
54. Reynolds AB,. p120-catenin: past and present. Biochim Biophys Acta 2007; 1773: 2-7.
55. Ichii T, Takeichi M,. p120-catenin regulates microtubule dynamics and cell migration in a cadherin-independent manner. Genes Cells 2007; 12: 827-839.
56. Yanagisawa M, Anastasiadis PZ,. p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness. J Cell Biol 2006; 174: 1087-1096.
57. Noren NK, Liu BP, Burridge K, et al,. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 2000; 150: 567-580.
58. Reynolds AB, Herbert L, Cleveland JL, et al,. p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene 1992; 7: 2439-2445.
59. Peifer M, Berg S, Reynolds AB,. A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 1994; 76: 789-791.
60. Reynolds AB, Daniel JM, Mo YY, et al,. The novel catenin p120cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts. Exp Cell Res 1996; 225: 328-337.
61. Chen H, Paradies NE, Fedor-Chaiken M, et al,. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J Cell Sci 1997; 110: 345-356.
62. Yap AS, Niessen CM, Gumbiner BM,. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol 1998; 141: 779-789.
63. Vieira AF RS, Ablett MP, Dionísio MR, et al,. P-cadherin is co-expressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem Cells 2012; 30: 854-864.
64. Derksen PW, Liu X, Saridin F, et al,. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006; 10: 437-449.
65. Fanelli MA, Montt-Guevara M, Diblasi AM, et al,. P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. Cell Stress Chaperones 2008; 13: 207-220.
66. Gamallo C, Moreno-Bueno G, Sarrio D, et al,. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod Pathol 2001; 14: 650-654.
67. Peralta Soler A, Knudsen KA, Salazar H, et al,. P-cadherin expression in breast carcinoma indicates poor survival. Cancer 1999; 86: 1263-1272.
68. Palacios J, Benito N, Pizarro A, et al,. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 1995; 146: 605-612.
69. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70.
70. Van Marck V, Stove C, Jacobs K, Van den Eynden G, Bracke M,. P-cadherin in adhesion and invasion: Opposite roles in colon and bladder carcinoma. Int J Cancer 2011; 128: 1031-1044.
71. Baek S, Lee YW, Yoon S, Baek SY, Kim BS, Oh SO,. CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells. Anat Cell Biol 2010; 43: 110-117.
72. Zhang CC, Yan Z, Zhang Q, Kuszpit K, Zasadny K, Qiu M, et al,. PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clin Cancer Res 2010; 16: 5177-5188.